Table of Contents

November 01, 2013; Volume 80, Issue 11
  • From the Editor

      • When people with diabetes go to surgery

        Brian F. Mandell, MD, PhD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 682;
        • DOI: https://doi.org/10.3949/ccjm.80b.11013
        • A key take-home point is that severely insulinopenic patients require some exogenous basal insulin, even when not eating.

  • Current Drug Therapy

      • Canagliflozin: Improving diabetes by making urine sweet

        Mary Vouyiouklis, MD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 683-687;
        • DOI: https://doi.org/10.3949/ccjm.80a.13053
        • Canagliflozin is the first of a new class of diabetes drugs that lower glucose by increasing its urinary excretion. An overview of its mechanism, uses, risks, and benefits.

  • The Clinical Picture

      • Dyspnea after treatment of recurrent urinary tract infection

        Krishna B. Ghimire, MD, Barsha Nepal and Mbbs
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 690-695;
        • DOI: https://doi.org/10.3949/ccjm.80a.120061
        • Glucose-6 phosphate dehydrogenase deficiency is an X-linked disorder that can present as hemolytic anemia after infection or exposure to certain medications.

      • A 66-year-old woman with an enlarged tongue

        Jorge A. Brenes-Salazar, MD, Martha Grogan, MD and Martha Q. Lacy, MD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 696-697;
        • DOI: https://doi.org/10.3949/ccjm.80a.13028
        • Eventually, she was diagnosed with multiple myeloma and cardiac amyloidosis.

  • 1-Minute Consult

      • How should we manage insulin therapy before surgery?

        Georgiana A. Dobri, MD and M. Cecilia Lansang, MD, MPH
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 702-704;
        • DOI: https://doi.org/10.3949/ccjm.80a.13055
        • Continuing at least part of the basal insulin is reasonable, but prandial insulin should be stopped the morning of surgery.

  • Review

      • TOC Icon

        Myasthenia gravis: Newer therapies offer sustained improvement

        Yuebing Li, MD, PhD, Yeeshu Arora, MD and Kerry Levin, MD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 711-721;
        • DOI: https://doi.org/10.3949/ccjm.80a.13044
        • The prognosis has dramatically improved; the death rate used to be 75%, now it is 4.5%.

      • Sleep disturbances in cancer patients: Underrecognized and undertreated

        Saurabh Dahiya, MD, Manmeet S. Ahluwalia, MD and Harneet K. Walia, MD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 722-732;
        • DOI: https://doi.org/10.3949/ccjm.80a.12170
        • In cancer patients, sleep disturbances are a treatable problem that profoundly affect all aspects of quality of life.

  • Departments

      • Paget disease of bone (July 2013)

        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 721;
        • An error appeared in Paget disease of bone: Diagnosis and drug therapy. Cleve Clin J Med 2013; 80:452–462.

      • Renal risk stratification with the new oral anticoagulants (July 2013)

        Patricio Pazmiño, PhD, MD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 733-734;
        • DOI: https://doi.org/10.3949/ccjm.80c.11001
        • Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).

      • In Reply: Renal risk stratification with the new oral anticoagulants (July 2013)

        Adewale Fawole, MD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 734;
        • DOI: https://doi.org/10.3949/ccjm.80c.11002
        • Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).

      • Not all joint pain is arthritis (May 2013)

        David L. Keller, MD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 734;
        • DOI: https://doi.org/10.3949/ccjm.80c.11003
        • Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).

      • In Reply: Not all joint pain is arthritis (May 2013)

        Gursimran Singh Kochhar, MD
        • Cleveland Clinic Journal of Medicine November 2013, 80 (11) 734;
        • DOI: https://doi.org/10.3949/ccjm.80c.11004
        • Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).